Drug Information

Drug General Information
Drug ID
D00MCN
Former ID
DNCL002362
Drug Name
AGS-16M8F
Indication Renal cancer [ICD9: 140-229, 189; ICD10:C64] Phase 1 [523023]
Company
Agensys Santa; Astellas Pharma
Target and Pathway
Target(s) Phosphodiesterase I beta Target Info Modulator [1572591]
References
Ref 523023ClinicalTrials.gov (NCT01114230) A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer. U.S. National Institutes of Health.
Ref 1572591Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.